SaifM. 2014. MM-398 Achieves Primary Endpoint of Overall Survival in Phase III Study in Patients with Gemcitabine Refractory Metastatic Pancreatic Cancer. JOP. Journal of the Pancreas. 15, 3 (May 2014), 278-279. DOI:https://doi.org/10.6092/1590-8577/2507.